Cameron Perks – Principal Analyst – Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Copyright 2023 – Finance News Network
Source: Finance News Network
29 May 2023 - Dr Andrew Tunks, Executive Chairman of Meteoric Resources (ASX:MEI), provides an update on the company's progress, discussing its transition from gold to rare earths, the advantages of ionic clay over hard rock deposits, and promising early results.
Read More10 Jul 2024 - The Honourable Shane Jones discusses the New Zealand government's pro-mining strategy. Topics touched on include: the rationale behind invigorating the resources sector, statutory reforms to boost investment, and commodities New Zealand possesses.
Read More19 Jun 2024 - Joe David, Managing Director of Elementos discusses the company's recent exciting discovery of high-grade copper and gold at the Cleveland Tin Project in Tasmania. Joe provides insights into the implications of this find, the project's background, and future exploration plans.
Read More21 Oct 2024 - Ken Morrison, CEO of the Bradfield Development Authority, discusses building Australia's first new city in a century, a high-tech urban project linked to the new Western Sydney International Airport.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More13 Aug 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.
Read More27 Jul 2022 - TerraCom Limited (ASX:TER) Managing Director Danny McCarthy discusses highlights of the company's June quarter results, the recent rains in Queensland, the mine life and run rate of the company's key asset Blair Athol and the outlook for coal.
Read More24 May 2021 - BluGlass Limited (ASX:BLG) Non-Executive Director Jean-Michel Pelaprat talks about joining BluGlass, his experience, and the future for BluGlass's gallium nitride technology.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More24 Feb 2025 - Immuno-oncology’s Expanding Role in Cancer Treatment
Read More
